Tatva Chintan Pharma Chem enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


3,777	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
10.7	5.8	11.4	45.4	27.4
120	120	36.4	14.3	170
3,887	—	—	—	—
110	115	25.0	−31.1	143
₹1,661.69	—	—	—	—

935	902	775	751	685
12.9%	13.3%	4.7%	1.9%	24.9%
0.03×	—	—	—	—

5.98×	—	—	—	—
30.70×	—	—	—	—
44.98×	—	—	—	—
650	506	383	394	424
127	93.2	34.2	68.2	60.6
86.4	56.3	6.6	42.6	51.0
—	31.5	24.7	98.0	27.8
−82.3	−82.3	−51.6	−30.5	−175
—	−83.0	−51.9	−32.5	−175
—	114	76.3	129	203

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

TATVA₹1,614.80

Tatva Chintan Pharma Chem Limited

· Chemicals

₹ CrorePeersVISHNU JUBLCPL KIRIINDUS FOSECOIND CHEMPLASTS DDEVPLSTIK GUJALKALI YASHOMcap ₹3,777 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	3,777.3
- Cash, Equiv & ST Investments	27.4	45.4	11.4	5.8	10.7
+ Total Debt	170.3	14.3	36.4	120.4	120.4
Enterprise Value	—	—	—	—	3,887.0
Net Debt (memo)	142.9	-31.1	25.0	114.6	109.7
EV per Share	—	—	—	—	1,661.69

Total Capital	685.0	751.4	775.2	902.1	935.0
Total Debt/Total Capital	24.85	1.90	4.69	13.34	12.87
Total Debt/EV	—	—	—	—	0.03

EV/Sales	—	—	—	—	5.98
EV/EBITDA	—	—	—	—	30.70
EV/EBIT	—	—	—	—	44.98
Reference Items — Trailing FY Values
Sales	423.6	393.5	382.7	505.9	649.9
EBITDA	60.6	68.2	34.2	93.2	126.6
EBIT	51.0	42.6	6.6	56.3	86.4
Operating Cash Flow	27.8	98.0	24.7	31.5	—
Free Cash Flow	-175.3	-30.5	-51.6	-82.3	-82.3
FCFF (free cash flow to the firm)	-175.3	-32.5	-51.9	-83.0	—
Capital Expenditure	203.1	128.5	76.3	113.8	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.